These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37684641)

  • 1. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer.
    Xie B; Lin J; Chen X; Zhou X; Zhang Y; Fan M; Xiang J; He N; Hu Z; Wang F
    Mol Cancer; 2023 Sep; 22(1):151. PubMed ID: 37684641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
    Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
    Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate promotes myogenesis via activating H3K9 lactylation-dependent up-regulation of Neu2 expression.
    Dai W; Wu G; Liu K; Chen Q; Tao J; Liu H; Shen M
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2851-2865. PubMed ID: 37919243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Lactylation Boosts Reparative Gene Activation Post-Myocardial Infarction.
    Wang N; Wang W; Wang X; Mang G; Chen J; Yan X; Tong Z; Yang Q; Wang M; Chen L; Sun P; Yang Y; Cui J; Yang M; Zhang Y; Wang D; Wu J; Zhang M; Yu B
    Circ Res; 2022 Nov; 131(11):893-908. PubMed ID: 36268709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
    Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
    J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites.
    Xu H; Li L; Wang S; Wang Z; Qu L; Wang C; Xu K
    Phytomedicine; 2023 Sep; 118():154940. PubMed ID: 37453194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression.
    Meng Q; Sun H; Zhang Y; Yang X; Hao S; Liu B; Zhou H; Xu ZX; Wang Y
    J Exp Clin Cancer Res; 2024 Jan; 43(1):36. PubMed ID: 38291438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    Zhou X; Zhang P; Han H; Lei H; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer.
    Li F; Zhang H; Huang Y; Li D; Zheng Z; Xie K; Cao C; Wang Q; Zhao X; Huang Z; Chen S; Chen H; Fan Q; Deng F; Hou L; Deng X; Tan W
    Drug Resist Updat; 2024 Mar; 73():101059. PubMed ID: 38295753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells.
    Pan L; Feng F; Wu J; Fan S; Han J; Wang S; Yang L; Liu W; Wang C; Xu K
    Pharmacol Res; 2022 Jul; 181():106270. PubMed ID: 35605812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone lactylation regulates cancer progression by reshaping the tumor microenvironment.
    Qu J; Li P; Sun Z
    Front Immunol; 2023; 14():1284344. PubMed ID: 37965331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
    Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
    Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
    Zeng Y; Xu Q; Xu N
    Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer.
    Wang D; Li Z; Li X; Yan C; Yang H; Zhuang T; Wang X; Zang Y; Liu Z; Wang T; Jiang R; Su P; Zhu J; Ding Y
    J Exp Clin Cancer Res; 2022 Jul; 41(1):219. PubMed ID: 35820928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.
    Dong L; Lin F; Wu W; Liu Y; Huang W
    Int J Med Sci; 2018; 15(6):645-652. PubMed ID: 29725256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation.
    Wang R; Xu F; Yang Z; Cao J; Hu L; She Y
    BMC Urol; 2024 Mar; 24(1):59. PubMed ID: 38481182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the interaction of glycolytic reprogramming with lactylation.
    Li Y; Cao Q; Hu Y; He B; Cao T; Tang Y; Zhou XP; Lan XP; Liu SQ
    Biomed Pharmacother; 2024 Aug; 177():116982. PubMed ID: 38906019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation.
    Wang X; Ying T; Yuan J; Wang Y; Su X; Chen S; Zhao Y; Zhao Y; Sheng J; Teng L; Luo C; Wang W
    Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder mesenchymal stromal cell-derived exosomal miRNA-217 modulates bladder cancer cell survival through Hippo-YAP pathway.
    Huang ZM; Wang H; Ji ZG
    Inflamm Res; 2021 Sep; 70(9):959-969. PubMed ID: 34390377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer.
    Wang F; Fan M; Zhou X; Yu Y; Cai Y; Wu H; Zhang Y; Liu J; Huang S; He N; Hu Z; Ding G; Jin X
    J Exp Clin Cancer Res; 2021 Jan; 40(1):44. PubMed ID: 33499877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.